Invention Grant
- Patent Title: Modified release formulations containing drug-ion exchange resin complexes
-
Application No.: US16241287Application Date: 2019-01-07
-
Publication No.: US10668163B2Publication Date: 2020-06-02
- Inventor: Ketan Mehta , Yu-Hsing Tu
- Applicant: Tris Pharma, Inc.
- Applicant Address: US PA Monmouth Junction
- Assignee: Tris Pharma, Inc.
- Current Assignee: Tris Pharma, Inc.
- Current Assignee Address: US PA Monmouth Junction
- Agency: Howson & Howson, LLP
- Agent Cathy A. Kodroff; Egon Berg
- Main IPC: A61K47/58
- IPC: A61K47/58 ; A61K31/135 ; A61K31/137 ; A61K31/155 ; A61K31/192 ; A61K31/216 ; A61K31/485 ; A61K9/00 ; A61K9/10 ; A61K9/16 ; A61K9/20 ; A61K47/69 ; A61K9/50 ; A61K31/4458 ; A61K9/14 ; A61K31/4402 ; A61K47/32 ; A61K31/24 ; A61K9/48 ; A61K47/14 ; A61K45/06
Abstract:
An aqueous liquid suspension containing a coated drug-ion exchange resin complex comprising a core composed of an amphetamine complexed with a pharmaceutically acceptable ion-exchange resin and an uncoated amphetamine-ion exchange resin complex is provided. The coated amphetamine-ion exchange resin complex is in admixture with a polymer to form a matrix. Methods of making the coated complex and the liquid suspension are described.
Public/Granted literature
- US20190142952A1 MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES Public/Granted day:2019-05-16
Information query
IPC分类:
